Meet our team
Welcome to our exceptional team, a group of highly skilled professionals driven by a common goal: to make a difference in the world of healthcare. With a diverse range of expertise and a shared passion for improving patient outcomes, our team is dedicated to delivering innovative solutions and creating a positive impact in the industry. Drawing upon extensive experience in market analysis, strategy, market access, lobbying, engagement with Key Opinion Leaders (KOLs), and patient organizations, we excel in navigating complex challenges and advocating for the needs of those with rare diseases. Our deep understanding of the pharmaceutical landscape, coupled with a strong track record in building top-class organizations, ensures that we are well-equipped to drive success and overcome obstacles. Together, we bring a wealth of knowledge, creativity, and a relentless drive for excellence. With a focus on collaboration, innovation, and patient-centricity, our team is poised to revolutionize the way healthcare is delivered. Join us on this transformative journey as we strive to provide patients with the right treatments and empower them to lead healthier, happier lives.
Jan Westerblad
Norwegian & Danish Expert
Jan started in the pharmaceutical industry in the early 1990s and since the beginning of the early 2000’s, his focus has been in the field of orphan/ultraorphan disease.
As Country Manager/General Manager, he has been involved/responsible for starting up Norwegian/Nordic commercial operations in several rare disease companies where he planned and executed commercialization strategies while building a strong scientific and commercial presence.
Lately, as a consultant, specializing in market access and public affairs, Jan has been advising companies on the importance of comprehensive market access strategies with early and diverse stakeholder involvement to successfully bring new therapies to patients with unmet medical needs.
Jan-Willem Schmitz
European & Netherlands Expert
Jan-Willem is an experienced Biopharma executive with a strong track record in building top-class organizations.
Jan-Willem has worked in different commercial roles at global, regional and local level, including general management and business operations. He has been active in a broad range of therapeutic indications; for 20 years he has been working in specialty care and since 2009 in rare diseases. He has been instrumental in building successful commercial organizations
Jan-Willem supports clients who are planning to commercialize in Europe; he advises on the full range of strategic and tactical commercialisation activities
Jari Pajasmaa
Finnish Expert
Jari is a master of market analysis, strategy, market access, lobbying, engagement with KoLs and patient organizations.
Jari has worked over 30 years in pharma industry with positions
in business development, sales, marketing and general management, the last twenty years with rare diseases and specialty drugs. He has also worked in IT sector and has knowledge in patient registries and data collection from hospital health records. He has been a pioneer in supporting genetic testing programs to diagnose rare disease patients.
His extensive key opinion leader network brings deep market understanding and high-level engagement with his clients.
Eva Rämme Bramberg
Swedish Expert
Eva is an experienced leader and business strategist with a strong background in life sciences, healthcare, recruitment, and consulting. She thrives on launching new initiatives, developing talent, and building networks that drive growth and innovation.
Her work spans start-ups, scale-ups, and established life science companies, supporting them with market entry, business transformation, interim leadership, and board services—across the Nordics and beyond.
Eva is also a passionate advocate for patient-centric innovation. She brings the patient perspective into strategic decision-making, ensuring that business growth aligns with real-world impact and improved health outcomes.
Known for her energy, clarity, and collaborative approach, Eva is a trusted advisor to both emerging and established players in the life science ecosystem.
Johnny Krogh Hansen
Danish & Nordic Expert
Johnny is a seasoned life science professional with deep expertise in biotech, ATMPs, and pharma, specializing in Country Management, New Business Development, and international account leadership across the Nordic region.
He combines scientific thinking with commercial strategy to drive growth, optimize profitability, and strengthen market presence. With a proven track record in complex technical sales, M&A integration, and product launches, Johnny brings pragmatic leadership and a results-driven mindset to every challenge.
Known for his authenticity, persistence, and ability to manage change, Johnny is a trusted partner to both national authorities and international stakeholders. He is goal-oriented, hands-on, and consistently delivers value through timely execution and strategic focus.
Stefan Nemec
European Expert
Stefan is a highly experienced pharmaceutical leader with over 30 years in the industry, including two decades focused specifically on rare diseases. Known for his all-round expertise, he has held key roles across leadership, market access, sales, and marketing in both large companies and innovative start-ups.
He has successfully built up affiliate operations in Austria, helping emerging companies establish a strong local presence. Stefan brings a strategic and structured mindset, along with a broad network of KOLs, peers, payors, and healthcare stakeholders.
With deep market insight and a pragmatic leadership style, Stefan is a trusted partner in navigating complex healthcare environments and accelerating access for rare disease therapies.
Annette Jäger Jardine
Nordic Expert
Annette is a creative and customer-focused leader with a strong track record in driving digital engagement, organizational transformation, and cross-functional collaboration. With a passion for building high-performing teams and a growth mindset, she delivers impactful results aligned with business goals.
She is known for initiating and leading innovative digital channel strategies that streamline communication, enhance customer experiences, and embed best practices across organizations. Annette also brings a deep commitment to patient advocacy, ensuring that patient needs and perspectives are integrated into digital and strategic initiatives.
With her agile mindset and strategic focus, Annette is a trusted partner in leading change, shaping culture, and unlocking business value through digital innovation.
Unlock rare market potential
Partner with ENTRI Access2Rare to navigate the complexities of rare disease market access in Europe, ensuring your therapeutic innovations reach those in need.